Where it may be relevant
- Older adults eligible under the current programme
- People with specified long-term conditions or immune risk
- Those needing review after spleen removal or impaired splenic function
Dose schedules.
The clinician will select the appropriate licensed schedule after reviewing age, health, previous doses and departure date.
Risk-based dose
Eligible adults
Dose 1Day 0
Some high-risk groups need later revaccination; current product choice must be checked.
Who may be eligible
- People meeting current age- or risk-based UKHSA criteria
- Product choice determined by the current programme, which may use newer conjugate vaccines rather than PPV23 in some groups
Who may not be eligible
- Anyone with a confirmed severe allergic reaction to a previous dose or a vaccine ingredient
- People who are acutely unwell with a significant fever may need vaccination deferred
- Pregnancy, breastfeeding, immune suppression and current medicines must be reviewed individually
Potential side effects
- Pain, redness or swelling where the injection is given
- Headache, tiredness, muscle aches or a mild fever
- Feeling faint around the time of vaccination
Important risks and precautions
- A severe allergic reaction is very rare and requires urgent treatment
- Protection is not absolute, so relevant food, water, bite or exposure precautions remain important
- The exact product and schedule must be confirmed during a clinical assessment
Clinical references
Further information.
Information is general and does not replace a personal assessment, prescribing decision or the latest destination-specific advice.